with nearly all subjects developing hepatitis A antibodies (anti-HAV) within 2 weeks. [3] However, a second dose of vaccine, given 6 or 12 to 18 months after the first dose in accordance with the ...
It is in the process of exploring the use of this drug in the phase 1a/1b AB-101-001 healthy volunteer study. This trial is recruiting both healthy volunteer patients and chronic Hepatitis B Virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback